Financials Sinocare Inc.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
23.17 ^CNY	0.00%		+16.32%	-23.78%

Apr. 26	Sinocare Inc. Proposes Final Dividend for 2023	CI
Apr. 25	Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	8,425	20,027	16,800	18,795	16,906	12,833	-	-
Enterprise Value (EV) ¹	8,425	20,027	16,800	18,795	16,906	12,833	12,833	12,833
P/E ratio	33.7 x	107 x	156 x	43.7 x	59.5 x	30.9 x	21.6 x	-
Yield	2%	-	-	0.59%	0.66%	1.01%	1.12%	-
Capitalization / Revenue	4.74 x	9.94 x	7.11 x	6.68 x	4.17 x	2.76 x	2.28 x	2.16 x
EV / Revenue	4.74 x	9.94 x	7.11 x	6.68 x	4.17 x	2.76 x	2.28 x	2.16 x
EV / EBITDA	24.5 x	62.3 x	41.8 x	32.4 x	35.9 x	19 x	14.5 x	13.6 x
EV / FCF	-	-	-	115 x	43.2 x	38.2 x	26.9 x	17.9 x
FCF Yield	-	-	-	0.87%	2.32%	2.62%	3.72%	5.58%
Price to Book	3.2 x	7.76 x	6.35 x	6.35 x	5.81 x	3.74 x	3.09 x	2.87 x
Nbr of stocks (in thousands)	562,014	559,413	561,673	557,223	556,128	553,845	-	-
Reference price ²	14.99	35.80	29.91	33.73	30.40	23.17	23.17	23.17
Announcement Date	2/14/20	4/16/21	4/21/22	4/6/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,778	2,015	2,361	2,814	4,059	4,650	5,638	5,930
EBITDA ¹	343.3	321.4	402.1	580.5	471.5	675.8	883.9	941.9
EBIT ¹	274.2	236.2	139.3	470.2	275	447.7	727.3	710.3
Operating Margin	15.42%	11.72%	5.9%	16.71%	6.78%	9.63%	12.9%	11.98%
Earnings before Tax (EBT) ¹	301.5	247.8	138.2	470	248.6	421.2	725.5	683.8
Net income ¹	250.7	186.9	107.6	430.9	284.4	420.4	606.1	627.3
Net margin	14.1%	9.27%	4.56%	15.31%	7.01%	9.04%	10.75%	10.58%
EPS ²	0.4445	0.3341	0.1916	0.7719	0.5107	0.7500	1.072	-
Free Cash Flow ¹	-	-	-	163.5	391.6	336.1	477.6	716.2
FCF margin	-	-	-	5.81%	9.65%	7.23%	8.47%	12.08%
FCF Conversion (EBITDA)	-	-	-	28.17%	83.05%	49.73%	54.03%	76.04%
FCF Conversion (Net income)	-	-	-	37.96%	137.7%	79.93%	78.8%	114.17%
Dividend per Share ²	0.3000	-	-	0.2000	0.2000	0.2350	0.2600	-
Announcement Date	2/14/20	4/16/21	4/21/22	4/6/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	164	392	336	478	716
ROE (net income / shareholders' equity)	9.5%	7.12%	3.87%	14.7%	9.24%	12.8%	14.7%	14.7%
ROA (Net income/ Total Assets)	-	-	-	9.83%	-	8.37%	9.3%	-
Assets ¹	-	-	-	4,385	-	5,025	6,517	-
Book Value Per Share ²	4.690	4.620	4.710	5.310	5.240	6.200	7.490	8.070
Cash Flow per Share ²	0.9200	0.8900	0.8500	0.8400	1.300	1.000	1.170	-
Capex ¹	422	276	404	311	344	345	334	207
Capex / Sales	23.73%	13.67%	17.1%	11.05%	8.46%	7.42%	5.92%	3.48%
Announcement Date	2/14/20	4/16/21	4/21/22	4/6/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

23.17 CNY

Average target price

31.01 CNY

Spread / Average Target

+33.85%

	1st Jan change	Capi.
SINOCARE INC.	-23.78%	1.77B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B